Biotech Stocks Pressured, Again (IBB)
Biotech stocks declined early on Thursday, with iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) lower by about 3%. The group is down over 10% in the past month.
Notable decliners included popular stocks like Pharmacyclics Inc. (Nasdaq: PCYC), Gilead Sciences Inc. (Nasdaq: GILD), Biogen Idec Inc. (Nasdaq: BIIB) and Celgene Corporation (Nasdaq: CELG), to name a few.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- IBM to buy HashiCorp in $6.4 billion deal to expand in cloud
- U.S. bank regulators extend comment period on Capital One-Discover deal
Create E-mail Alert Related Categories
ETFs, General News, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!